Clinical Trials Directory

Trials / Sponsors / Response Pharmaceuticals

Response Pharmaceuticals

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedEffects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
Triglycerides, Weight Gain Trajectory, Cholesterol, Elevated
Phase 22024-09-27
CompletedEffect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
Drug-induced Weight Gain
Phase 12023-05-16
CompletedStudy of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 22015-04-01
CompletedA Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2
Type 2 Diabetes
Phase 22009-04-01
CompletedComparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyp
Hyperlipidemia
Phase 22009-01-01
CompletedSafety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension
Hypertension
Phase 22007-07-01
CompletedSafety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension
Hypertension
Phase 22007-06-01
CompletedSafety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
Raynaud's Disease
Phase 22007-06-01
CompletedEvaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides
Hypertriglyceridemia
Phase 22007-05-01